Reasons that patients with acute myelogenous leukemia do not undergo allogeneic bone marrow transplantation

New England Journal of Medicine

Volumn 326, Issue 3, 1992, Pages 156-160

  Berman, Ellin ^a   Little, Claudia ^a   Gee, Timothy ^a   Clarkson, Bayard ^a   O'reilly, Richard ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACUTE GRANULOCYTIC LEUKEMIA; ADOLESCENT; ALLOGENIC BONE MARROW TRANSPLANTATION; ARTICLE; HLA TYPING; HUMAN; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; REMISSION; SCHOOL CHILD; STATISTICS;

ADULT; AGE FACTORS; BONE MARROW TRANSPLANTATION; HISTOCOMPATIBILITY TESTING; HLA ANTIGENS; HUMAN; LEUKEMIA, MYELOCYTIC, ACUTE; REMISSION INDUCTION; SUPPORT, NON-U.S. GOV'T; TRANSPLANTATION, HOMOLOGOUS;

EID: 0026334775     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJM199201163260303     Document Type: Article

References (25)

1. Applcbaum F.R., Fisher L.D., Thomas E.D. Chemotherapy v marrow transplantation for adults with acute nonlymphocytic leukemia: a five-year follow-up. Blood 1988; 72:179-184
2. Champlin R.E., Ho W.G., Gale R.P., et al. Treatment of acute myelogenous leukemia: a prospective controlled trial of bone marrow transplantation versus consolidation chemotherapy. Ann Intern Med 1985:102:285-291
3. Geller R.B., Saral R., Piantadosi S., et al. Allogeneic bone marrow transplantation after high-dose busulfan and cyclophosphamide in patients with acute nonlymphocytic leukemia. Blood 1989; 73:2209-2218
4. McGlave P.B., Haake R.J., Bostrom B.C., et al. Allogeneic bone marrow transplantation for acute nonlymphocytic leukemia in first remission. Blood 1988; 72:1512-1517
5. Report from the Working Party on Leukaemia, European Group for Bone Marrow Transplantation. Allogeneic bone marrow transplantation for leukaemia in Europe. Lancet 1988; 1:1379-1382
6. Forman S.J., Krance R.A., O#x0027;Donnell M.R., et al. Bone marrow transplantation for acute nonlymphoblastic leukemia during first complete remission. Transplantation 1987; 43:650-653
7. Young J.W., Papadopoulus E., Carabasi M., et al. T-cell depleted allogenic bone marrow transplantation in adults with ANLL in first remission. Blood 1990; 76:Suppl:575a
8. Cunningham I., Gee T.S., Reich L.M., Kempin S.J., Naval A.N., Clarkson B.D. Acute promyelocytic leukemia: treatment results during a decade at Memorial Hospital. Blood 1989; 73:1116-1122
9. Kantarjian H.M., Keating M.J., Walters R.S., Smith T.L., McCredie K.B., Freireich E.J. Role of maintenance chemotherapy in acute promyelocytic leukemia. Cancer 1987; 59:1258-1263
10. Stone R.M., Maguire M., Goldberg M.A., Antin J.H., Rosenthal D.S., Mayer R.J. Complete remission in acute promyelocytic leukemia despite peristence of abnormal bone marrow promyelocytes during induction therapy: experience in 34 patients. Blood 1988; 71:690-696
11. Clarkson B., Berman E., Little C., et al. Update on clinical trials of chemotherapy and bone marrow transplantation in acute myelogenous leukemia in adults at Memorial Sloan Kettering Cancer Center (MSKCC) 1966–1989. In: Gale RP, ed. Acute myelogenous leukemia: progress and controversies. Philadelphia: Wiley-Liss, 1990: 231-52.
12. Brincker H. Estimate of overall treatment results in acute nonlymphocytic leukemia based on age-specific rates of incidence and of complete remission. Cancer Treat Rep 1985; 69:5-11.
13. Chan K.-W., Pollack M.S., Braun D. Jr., O#x0027;Reilly R.J., Dupont B. Distribution of HLA genotypes in families of patients with acute leukemia. Transplantation 1982; 33:613-615
14. Council on Ethical and Judicial Affairs, American Medical Association. Gender disparities in clinical decision making. JAMA 1991; 266:559-562
15. Hermans J., Suciu S., Stijnen T.H., et al. Treatment of acute myelogenous leukemia: an EBMT-EORTC retrospective analysis of chemotherapy versus allogeneic or autologous bone marrow transplantation. Eur J Cancer Clin Oncol 1989; 25:545-550
16. Zander A.R., Keating M., Dicke K., et al. A comparison of bone marrow transplantation with chemotherapy for adults with acute leukemia of poor prognosis in first complete remission. J Clin Oncol 1988; 6:1548-1557
17. Lowenberg B., Verdonck L.J., Dekker A.W., et al. Autologous bone marrow transplantation in acute myeloid leukemia in first remission: results of a Dutch prospective study. J Clin Oncol 1990; 8:287-294
18. Berman E., Heller G., Santorsa J., et al. Results of a randomized trial comparing idarubicin and cytosine arabinoside with daunorubicin and cytosine arabinoside in adult patients with newly diagnosed acute myelogenous leukemia. Blood 1991; 77:1666-1674
19. Bishop J.F., Lowenthal R.M., Joshua D., et al. Etoposide in acute nonlymphoblastic leukemia. Blood 1990; 75:27-32.
20. Yates J., Glidewell O., Wiernik P., et al. Cytosine arabinoside with daunorubicin or adriamycin for therapy of acute myelocytic leukemia: a CALGB study. Blood 1982; 60:454-462
21. Rai K.R., Holland J.F., Glidewell O.J., et al. Treatment of acute myelocytic leukemia: a study by Cancer and Acute Leukemia Group B. Blood 1981; 58:1203-1212
22. Cassileth P.A., Begg C.B., Bennett J.M., et al. A randomized study of the efficacy of consolidation therapy in adult acute nonlymphoblastic leukemia. Blood 1984; 63:843-847
23. Weinstein H.J., Mayer R.J., Rosenthal D.S., et al. Treatment of acute myelogenous leukemia in children and adults. N Engl J Med 1980; 303:473-478
24. Arlin Z., Case D.C. Jr., Moore J., et al. Randomized multicenter trial of cytosine arabinoside with mitoxantrone or daunorubicin in previously untreated adult patients with acute nonlymphocytic leukemia (ANLL). Leukemia 1990; 4:177-183
25. Preisler H.P., Rustum Y., Henderson E.S., et al. Treatment of acute nonlymphocytic leukemia: use of anthracycline-cytosine arabinoside induction therapy and comparison of two maintenance regimens. Blood 1979; 53:455-464